These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
237 related articles for article (PubMed ID: 11960325)
1. Identification of novel targets for cancer therapy using expression proteomics. Hanash SM; Madoz-Gurpide J; Misek DE Leukemia; 2002 Apr; 16(4):478-85. PubMed ID: 11960325 [TBL] [Abstract][Full Text] [Related]
2. Global profiling of gene expression in cancer using genomics and proteomics. Hanash SM Curr Opin Mol Ther; 2001 Dec; 3(6):538-45. PubMed ID: 11804268 [TBL] [Abstract][Full Text] [Related]
3. Genomic and proteomic technologies for individualisation and improvement of cancer treatment. Wulfkuhle J; Espina V; Liotta L; Petricoin E Eur J Cancer; 2004 Nov; 40(17):2623-32. PubMed ID: 15541963 [TBL] [Abstract][Full Text] [Related]
4. Proteomic profiling predicts drug response to novel targeted anticancer therapeutics. Lin F; Li Z; Hua Y; Lim YP Expert Rev Proteomics; 2016; 13(4):411-20. PubMed ID: 26954459 [TBL] [Abstract][Full Text] [Related]
5. Proteomics and the analysis of proteomic data: an overview of current protein-profiling technologies. Gulcicek EE; Colangelo CM; McMurray W; Stone K; Williams K; Wu T; Zhao H; Spratt H; Kurosky A; Wu B Curr Protoc Bioinformatics; 2005 Jul; Chapter 13():Unit 13.1. PubMed ID: 18428746 [TBL] [Abstract][Full Text] [Related]
10. Membrane proteomics for leukemia classification and drug target identification. Kohnke PL; Mulligan SP; Christopherson RI Curr Opin Mol Ther; 2009 Dec; 11(6):603-10. PubMed ID: 20072937 [TBL] [Abstract][Full Text] [Related]
11. Proteomics-based anticancer drug discovery and development. Jain KK Technol Cancer Res Treat; 2002 Aug; 1(4):231-6. PubMed ID: 12625781 [TBL] [Abstract][Full Text] [Related]
12. Towards a comprehensive understanding of Bacillus subtilis cell physiology by physiological proteomics. Hecker M; Völker U Proteomics; 2004 Dec; 4(12):3727-50. PubMed ID: 15540212 [TBL] [Abstract][Full Text] [Related]
13. Proteomics of the heart: unraveling disease. McGregor E; Dunn MJ Circ Res; 2006 Feb; 98(3):309-21. PubMed ID: 16484627 [TBL] [Abstract][Full Text] [Related]
14. Gene expression profiling: monitoring transcription and translation products using DNA microarrays and proteomics. Celis JE; Kruhøffer M; Gromova I; Frederiksen C; Ostergaard M; Thykjaer T; Gromov P; Yu J; Pálsdóttir H; Magnusson N; Orntoft TF FEBS Lett; 2000 Aug; 480(1):2-16. PubMed ID: 10967322 [TBL] [Abstract][Full Text] [Related]
15. Proteomics-based strategy to identify biomarkers and pharmacological targets in leukemias with t(4;11) translocations. Yocum AK; Busch CM; Felix CA; Blair IA J Proteome Res; 2006 Oct; 5(10):2743-53. PubMed ID: 17022645 [TBL] [Abstract][Full Text] [Related]
16. Application of proteomic technologies to tumor analysis. Misek DE; Imafuku Y; Hanash SM Pharmacogenomics; 2004 Dec; 5(8):1129-37. PubMed ID: 15584879 [TBL] [Abstract][Full Text] [Related]
17. Chemical strategies for functional proteomics. Adam GC; Sorensen EJ; Cravatt BF Mol Cell Proteomics; 2002 Oct; 1(10):781-90. PubMed ID: 12438561 [TBL] [Abstract][Full Text] [Related]
18. Application of targeted mass spectrometry in bottom-up proteomics for systems biology research. Manes NP; Nita-Lazar A J Proteomics; 2018 Oct; 189():75-90. PubMed ID: 29452276 [TBL] [Abstract][Full Text] [Related]
19. Proteomics in postgenomic neuroscience: the end of the beginning. Choudhary J; Grant SG Nat Neurosci; 2004 May; 7(5):440-5. PubMed ID: 15114355 [TBL] [Abstract][Full Text] [Related]
20. Technologies for the study of gene and protein expression in Plasmodium. Carucci DJ Philos Trans R Soc Lond B Biol Sci; 2002 Jan; 357(1417):13-6. PubMed ID: 11839177 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]